(Total Views: 390)
Posted On: 02/25/2019 3:11:25 PM
Post# of 72441
I am so interested, how PIII trial design will look like??
With interim analysis or without ??
With "cross over" design or not
Trial end points being similar to PII or other important end points will be added eg. QoL ??
Will OM induced by chemo alone ( 5FU , topotecan and other drugs) will be added to expend the cohort of patients and by that quicken the trial and widen indications for B-OM beyond chemo-radiation
Very exiting times for all of us longs
aragon
With interim analysis or without ??
With "cross over" design or not
Trial end points being similar to PII or other important end points will be added eg. QoL ??
Will OM induced by chemo alone ( 5FU , topotecan and other drugs) will be added to expend the cohort of patients and by that quicken the trial and widen indications for B-OM beyond chemo-radiation
Very exiting times for all of us longs
aragon
(2)
(0)Scroll down for more posts ▼
